Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic.

Autor: van Lierop, Zoë YGJ, Wessels, Mark HJ, Lekranty, Womei ML, Moraal, Bastiaan, Hof, Sam N, Hogenboom, Laura, de Jong, Brigit A, Meijs, Nandi, Mensing, Liselore A, van Oosten, Bob W, Sol, Nik, van Kempen, Zoé LE, Vermunt, Lisa, Willems, Myrthe J, Strijbis, Eva MM, Uitdehaag, Bernard MJ, Killestein, Joep, Teunissen, Charlotte E

Publikováno v: Multiple Sclerosis Journal; Nov2024, Vol. 30 Issue 13, p1620-1629, 10p

sj-docx-1-msj-10.1177_13524585221118676 – Supplemental material for Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis

Autor: van Lierop, Zoë YGJ, Noteboom, Samantha, Steenwijk, Martijn D, van Dam, Maureen, Toorop, Alyssa A, van Kempen, Zoé LE, Moraal, Bastiaan, Barkhof, Frederik, Uitdehaag, Bernard MJ, Schoonheim, Menno M, Teunissen, Charlotte E, Killestein, Joep

Supplemental material, sj-docx-1-msj-10.1177_13524585221118676 for Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis by Zoë YGJ van Lierop, Samantha Noteboom, M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c4db7e9d3b761451b87b886cabf0157

sj-pdf-1-msj-10.1177_13524585211010097 – Supplemental material for Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis

Autor: Van Lierop, Zoë YGJ, Wieske, Luuk, Koel-Simmelink, Marleen JA, Madhurima Chatterjee, Dekker, Iris, Leurs, Cyra E, Willemse, Eline AJ, Moraal, Bastiaan, Barkhof, Frederik, Eftimov, Filip, Uitdehaag, Bernhard MJ, Killestein, Joep, Teunissen, Charlotte E

Supplemental material, sj-pdf-1-msj-10.1177_13524585211010097 for Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis by Zoë YGJ van Lierop, Luuk Wieske, Marleen JA Koel-Simmelink, Madhurima Ch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3013afb6fa0c185f064d0334bb9ed6e4

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.

Autor: van Lierop, Zoë YGJ, Wieske, Luuk, Koel-Simmelink, Marleen JA, Chatterjee, Madhurima, Dekker, Iris, Leurs, Cyra E, Willemse, Eline AJ, Moraal, Bastiaan, Barkhof, Frederik, Eftimov, Filip, Uitdehaag, Bernhard MJ, Killestein, Joep, Teunissen, Charlotte E

Publikováno v: Multiple Sclerosis Journal; Jan2022, Vol. 28 Issue 1, p102-110, 9p

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).

Autor: Toorop AA; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands a.toorop@amsterdamumc.nl., van Lierop ZY; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Gelissen LM; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Hoitsma E; Department of Neurology, MS Center, Alrijne Hospital, Leiden, The Netherlands., Zeinstra EM; Department of Neurology, Isala, Meppel, The Netherlands., van Rooij LC; Department of Neurology, Maasstad Hospital, Rotterdam, The Netherlands., van Munster CE; Department of Neurology, Amphia Hospital, Breda, The Netherlands., Vennegoor A; Department of Neurology, Flevoziekenhuis, Almere, The Netherlands., Mostert JP; Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands., Wokke BH; Department of Neurology, ErasMS, Erasmus Medical Center, Rotterdam, The Netherlands., Kalkers NF; Department of Neurology, OLVG Hospital, Amsterdam, The Netherlands., Hoogervorst EL; Department of Neurology, St Antonius Hospital, Utrecht, Netherlands., van Eijk JJ; Department of Neurology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Roosendaal CM; Department of Neurology, Slingeland Hospital, Doetinchem, The Netherlands., Kragt JJ; Department of Neurology, Reinier de Graaf Hospital, Delft, The Netherlands., Eurelings M; Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands., van Genugten J; Department of Neurology, Ziekenhuisgroep Twente, Almelo, The Netherlands., Nielsen J; Department of Neurology, Ommelander Hospital Groningen, Scheemda, The Netherlands., Sinnige L; Department of Neurology, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Kloosterziel ME; Department of Neurology, Wilhelmina Hospital Assen, Assen, The Netherlands., Arnoldus EP; Department of Neurology, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands., van Dijk GW; Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Bouvy WH; Department of Neurology, Diakonessenhuis Hospital, Utrecht, The Netherlands., Wessels MH; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Boonkamp L; Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., Strijbis EM; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., van Oosten BW; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., De Jong BA; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Lissenberg-Witte BI; Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., Barkhof F; Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.; Queen Square MS Centre, Department of Neuroinflammation, Faculty of Brain Sciences, University College London Hospitals and National Institute for Health Research, London, UK., Moraal B; Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands., Rispens T; Diagnostic Services and Immunopathology, Sanquin Research, Amsterdam, The Netherlands.; Department of Immunopathology, Landsteiner Laboratory, University of Amsterdam, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands., Uitdehaag BM; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Killestein J; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., van Kempen ZL; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.

Publikováno v: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2024 Apr 12; Vol. 95 (5), pp. 392-400. Date of Electronic Publication: 2024 Apr 12.